1,410 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
3 Stocks to Buy With Dividends Yielding 3% or More https://www.fool.com/investing/2017/06/08/3-stocks-to-buy-with-dividends-yielding-3-or-more.aspx?source=iedfolrf0000001 Jun 08, 2017 - Looking for both good yields and solid business prospects is important. These stocks deliver the goods.
Novartis Presents Data on Tafinlar-Mekinist Combination http://www.zacks.com/stock/news/263072/novartis-presents-data-on-tafinlar-mekinist-combination?cid=CS-ZC-FT-263072 Jun 05, 2017 - Novartis AG (NVS) announced results from a phase II study, BRF113220, on the combination of Tafinlar and Mekinist at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO).
Novartis AG (NVS) Investor Presentation - Slideshow https://seekingalpha.com/article/4078060-novartis-ag-nvs-investor-presentation-slideshow?source=feed_all_articles Jun 01, 2017 - The following slide deck was published by Novartis AG in conjunction with this event.
Novartis Biosimilar Pipeline, 2018 Growth Plans on Track http://www.zacks.com/stock/news/262554/novartis-biosimilar-pipeline-2018-growth-plans-on-track?cid=CS-ZC-FT-262554 May 31, 2017 - Novartis AG (NVS) announced that the EMA has accepted its applications for biosimilar versions of AbbVie's (ABBV) Humira (adalimumab) and Johnson & Johnson's (JNJ) Remicade (infliximab) for review.
Celgene's Stock May Be Incredibly Overvalued Right Now -- Here's Why https://www.fool.com/investing/2017/05/31/celgenes-stock-may-be-incredibly-overvalued-right.aspx?source=iedfolrf0000001 May 31, 2017 - Celgene's long thesis might be unraveling.
5 Drug Stocks in Focus on World MS Day http://www.zacks.com/stock/news/262510/5-drug-stocks-in-focus-on-world-ms-day?cid=CS-ZC-FT-262510 May 31, 2017 - Life with MS -- this world MS day, here's a look at 5 stocks including Biogen (BIIB) that are key players in the multiple sclerosis (MS) market.
The 5 Best Dividend Stocks in Cholesterol Drugs https://www.fool.com/investing/2017/05/30/the-5-best-dividend-stocks-in-cholesterol-drugs.aspx?source=iedfolrf0000001 May 30, 2017 - Looking for great dividend stocks of companies that make cholesterol drugs? Check out Amgen, AstraZeneca, Novartis, Pfizer, and Sanofi.
Intercept's (ICPT) Liver Drug Ocaliva Approved in Canada http://www.zacks.com/stock/news/262195/intercepts-icpt-liver-drug-ocaliva-approved-in-canada?cid=CS-ZC-FT-262195 May 29, 2017 - Intercept Pharmaceuticals, Inc. (ICPT) announced that livver drug Ocaliva has obtained approval in Canada also.
Kite Pharma Cancer Drug BLA Gets Priority Review Status http://www.zacks.com/stock/news/262178/kite-pharma-cancer-drug-bla-gets-priority-review-status?cid=CS-ZC-FT-262178 May 29, 2017 - Kite Pharma, Inc. (KITE) announced that its biologics license application (BLA) for its experimental CAR-T therapy, axicabtagene ciloleucel has been accepted for priority review by the FDA.
3 Top Dividend Stocks in Generic Drugs https://www.fool.com/investing/2017/05/26/3-top-dividend-stocks-in-generic-drugs.aspx?source=iedfolrf0000001 May 26, 2017 - Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry.
<<<Page 121>